J&J Files 8-K on Debt Issuances

TL;DR

J&J dropped an 8-K on a bunch of new debt notes – check the rates and maturities.

AI Summary

On September 20, 2024, Johnson & Johnson filed an 8-K report detailing various debt issuances. These include notes due in 2024, 2028, 2032, 2035, 2036, and 2044, with coupon rates ranging from 1.150% to 5.50%. This filing is primarily for informational purposes regarding their ongoing financing activities.

Why It Matters

This filing provides transparency into Johnson & Johnson's capital structure and ongoing debt management, which can influence investor perception of its financial health and borrowing costs.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of debt issuances and does not indicate any unusual financial distress or significant new risks.

Key Numbers

• 5.50% — Notes Due 2024 Coupon Rate (Represents the highest coupon rate disclosed for the notes.)
• 1.150% — Notes Due Nov 2028 Coupon Rate (Represents the lowest coupon rate disclosed for the notes.)

Key Players & Entities

• JOHNSON & JOHNSON (company) — Registrant
• September 20, 2024 (date) — Report Date
• 5.50% (dollar_amount) — Coupon rate for notes due 2024
• 1.150% (dollar_amount) — Coupon rate for notes due November 2028
• 3.20% (dollar_amount) — Coupon rate for notes due November 2032
• 1.650% (dollar_amount) — Coupon rate for notes due 2035
• 3.350% (dollar_amount) — Coupon rate for notes due November 2036
• 3.550% (dollar_amount) — Coupon rate for notes due November 2044

FAQ

Key Financial Figures

• $1.00 — ich registered Common Stock, Par Value $1.00 JNJ New York Stock Exchange 5.50% Note
• $1.75 billion — e its contribution to the settlement by $1.75 billion to a present value of approximately $8
• $8 billion — ion to a present value of approximately $8 billion. The press release further discussing

Filing Documents

• jnj-20240920.htm (8-K) — 35KB
• a2024q3exhibit991talc1.htm (EX-99.1) — 20KB
• image_0a.jpg (GRAPHIC) — 0KB
• image_1a.jpg (GRAPHIC) — 19KB
• 0000200406-24-000083.txt ( ) — 278KB
• jnj-20240920.xsd (EX-101.SCH) — 4KB
• jnj-20240920_def.xml (EX-101.DEF) — 8KB
• jnj-20240920_lab.xml (EX-101.LAB) — 33KB
• jnj-20240920_pre.xml (EX-101.PRE) — 20KB
• jnj-20240920_htm.xml (XML) — 8KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On September 20, 2024, the Company announced that its subsidiary, Red River Talc LLC ("Red River"), filed a voluntary prepackaged Chapter 11 bankruptcy case today in the in U.S. Bankruptcy Court for the Southern District of Texas Houston Division to fully and finally resolve of all current and future claims related to ovarian cancer arising from cosmetic talc litigation against the Company and its affiliates in the United States. Red River filed the bankruptcy case after it received the support of the overwhelming majority (approximately 83%) of the current claimants for the proposed bankruptcy plan (the "Plan"). After extensive negotiations with counsel for claimants who initially opposed the Plan, Red River agreed to increase its contribution to the settlement by $1.75 billion to a present value of approximately $8 billion. The press release further discussing this announcement is attached below as Exhibit 99.1.

01 Financial statements and exhibits

Item 9.01 Financial statements and exhibits (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Press Release dated September 20 , 2024 . 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

Signatures

Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 20, 2024 JOHNSON & JOHNSON (Registrant) By: /s/ Robert J. Decker, Jr. Robert J. Decker, Jr. Controller (Principal Accounting Officer)

View Full Filing

View this 8-K filing on SEC EDGAR